DekaBank Deutsche Girozentrale’s Usana Health Sciences USNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,746	Closed	-$1.96M	–	1279
2019 Q1	$1.96M	Buy	14,746 +11,754	+393%	+$1.23M	0.01%	614
2018 Q4	$344K	Sell	2,992 -11,754	-80%	-$1.36M	﹤0.01%	892
2018 Q3	$1.96M	Hold	14,746	–	–	0.01%	627
2018 Q2	$1.7M	Sell	14,746 -12,326	-46%	-$1.35M	0.01%	623
2018 Q1	$2.35M	Buy	27,072 +19,099	+240%	+$1.48M	0.02%	542
2017 Q4	$454K	Hold	7,973	–	–	﹤0.01%	842
2017 Q3	$454K	Buy	7,973 +2,732	+52%	+$161K	﹤0.01%	848
2017 Q2	$337K	Buy	+5,241	New	+$323K	﹤0.01%	885
2015 Q4	–	Sell	-386	Closed	-$26K	–	1137
2015 Q3	$26K	Sell	386 -188	-33%	-$13.3K	﹤0.01%	1082
2015 Q2	$39K	Hold	574	–	–	﹤0.01%	1106
2015 Q1	$32K	Sell	574 -158	-22%	-$8.1K	﹤0.01%	1097
2014 Q4	$38K	Hold	732	–	–	﹤0.01%	1040
2014 Q3	$27K	Buy	+732	New	+$26.4K	﹤0.01%	1015
2014 Q2	–	Sell	-33,206	Closed	-$1.25M	–	990
2014 Q1	$1.25M	Hold	33,206	–	–	0.02%	443
2013 Q4	$1.29M	Hold	33,206	–	–	0.02%	383
2013 Q3	$1.44M	Hold	33,206	–	–	0.03%	363
2013 Q2	$1.2M	Buy	+33,206	New	+$1.01M	0.02%	343

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DekaBank Deutsche Girozentrale's USNA Position: Q2 2019 in Review

DekaBank Deutsche Girozentrale sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 14,746 shares — an estimated $1.96M sold.

DekaBank Deutsche Girozentrale first reported a position in USNA in Q2 2013 and held it in 17 quarters. The position peaked at $2.35M in Q1 2018. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

DekaBank Deutsche Girozentrale reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 14,746 Usana Health Sciences shares in Q2 2019, an estimated $1.96M.
DekaBank Deutsche Girozentrale first reported a position in Usana Health Sciences in Q2 2013 and held it in 17 quarters.
DekaBank Deutsche Girozentrale's Usana Health Sciences position peaked at $2.35M in Q1 2018.
173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.